Invention Grant
- Patent Title: Ureido-thiazole glucokinase activators
- Patent Title (中): 脲基 - 噻唑葡糖激酶活化剂
-
Application No.: US11994862Application Date: 2006-07-14
-
Publication No.: US07884210B2Publication Date: 2011-02-08
- Inventor: Jesper Lau , Anthony Murray , Per Vedso , Marit Kristiansen , Lone Jeppesen
- Applicant: Jesper Lau , Anthony Murray , Per Vedso , Marit Kristiansen , Lone Jeppesen
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Rosemarie R. Wilk-Orescan
- Priority: EP05106449 20050714
- International Application: PCT/EP2006/064289 WO 20060714
- International Announcement: WO2007/006814 WO 20070118
- Main IPC: C07D277/00
- IPC: C07D277/00
Abstract:
The invention provides a compound of general formula (I) wherein the compounds are of the class ureido-thiazole glucokinase activators, useful for the treatment of various diseases, for example, type 2 diabetes.
Public/Granted literature
- US20090105482A1 Urea Glucokinase Activators Public/Granted day:2009-04-23
Information query
